1-(2-((5-Chloropyridin-3-yl)oxy)ethyl)piperazine → 1-[4-Cyano-4-(5-cyano-2-thienyl)-5-methylhexyl]-4-[2-(5-chloro-3-pyridyloxy)ethyl]piperazine
반응식
[C:1](#[N:2])[C:3]([CH2:4][CH2:5][CH2:6][I:7])([CH:8]([CH3:9])[CH3:10])[c:11]1[s:12][c:13]([C:16]#[N:17])[cH:14][cH:15]1.[Cl:18][c:19]1[cH:20][c:21]([O:25][CH2:26][CH2:27][N:28]2[CH2:29][CH2:30][NH:31][CH2:32][CH2:33]2)[cH:22][n:23][cH:24]1>>[C:1](#[N:2])[C:3]([CH2:4][CH2:5][CH2:6][N:31]1[CH2:30][CH2:29][N:28]([CH2:27][CH2:26][O:25][c:21]2[cH:20][c:19]([Cl:18])[cH:24][n:23][cH:22]2)[CH2:33][CH2:32]1)([CH:8]([CH3:9])[CH3:10])[c:11]1[s:12][c:13]([C:16]#[N:17])[cH:14][cH:15]1참가 물질
3
출처 및 근거
- ORD 기록
- ord-69797c2fe8984e39a3b3ee7c4ab93316
- 출처 데이터셋
- Training data from https://doi.org/10.1039/C8SC04228D (3/10)
반응 노트
불러오는 중…